Retension Pharmaceuticals, Inc. (RTSN): Form 8-K filed 2026-10-13
- Accepted by EDGAR
- 2026-10-13 16:06 ET
- Event date
- 2026-10-09
- Accession no.
- 0001213900-26-109024
- Original filing
- SEC EDGAR filing index
Items reported
- Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0308462-8k_retension.htm |
| EX-3.1 | AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF RETENSION PHARMACEUTICALS, | ea030846201ex3-1.htm |
| EX-3.2 | AMENDED AND RESTATED BYLAWS OF RETENSION PHARMACEUTICALS, INC. | ea030846201ex3-2.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.